Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection
Open Access
- 1 December 1990
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 82 (3) , 479-484
- https://doi.org/10.1111/j.1365-2249.1990.tb05475.x
Abstract
Tumour necrosis factor‐alpha (TNF‐α), a cytokine derived from macrophages, is considered to bean important endogenous mediator of endotoxic shock. Patients with fulminant hepatic failure are particularly susceptible to infection and the development of multi‐organ failure and similarities to endotoxic shock suggest a possible pathogenetic role for TNF in fulminant hepatic failure. In vitro TNF production was therefore investigated serially in 21 consecutive patients with fulminant hepatic failure and in 21 healthy controls. Spontaneous and lipopolysaccharide‐stimulated TNF production were elevated in viral‐induced fulminant hepatic failure, compared with healthy controls (P < 0.05 and P P < 0.02); this difference was present throughout admission. In this group elevations in TNF production above baseline were associated with Gram‐positive bacterial or fungal infection but not Gram‐negative bacterial infection. There was no correlation between any of the clinical complications of fulminant hepatic failure and TNF production. These studies indicate that TNF is produced in response to microbial stimuli in fulminant hepatic failure, but do not support a direct role for TNF in the evolution of the clinical complications of fulminant hepatic failure.Keywords
This publication has 29 references indexed in Scilit:
- Natural Production and Release of Tumour Necrosis FactorPublished by Wiley ,2007
- Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious PurpuraNew England Journal of Medicine, 1988
- ENHANCED TUMOUR NECROSIS FACTOR AND INTERLEUKIN-1 IN FULMINANT HEPATIC FAILUREThe Lancet, 1988
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- Detection of Hybridomas Secreting Monoclonal Antibodies to Human Gamma Interferon Using a Rapid Screening Technique and Specificity of Certain Monoclonal Antibodies to Gamma InterferonJournal of Interferon Research, 1984
- Reticuloendothelial system and hepatocytic function in fulminant hepatic failure.Gut, 1982
- Bacteraemia in patients with fulminant hepatic failureLiver International, 1982